Skyepharma

Skyepharma is a key player in drug development and oral technology delivery, serving the global pharmaceutical, biotechnology, and consumer health industries. In 2016, Skyepharma became the oral business unit of Vectura Group, operating as a CDMO specializing in oral solid forms. The company's mission is to provide product development, manufacturing, and packaging services to the healthcare industry through state-of-the-art facilities, scientific expertise, and open, transparent relationships.